Business Medical Dialogues

RSS Feed URL: http://business.medicaldialogues.in/feed/
Category: Health | Total Views: 58

Latest entries from this feed

Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila

Posted on 23 September 2018 | 3:30 am by MD Team

Biocon and pharma firm Mylan said CHMP has a positive opinion recommending approval for their pegfilgrastim biosimilar, Fulphila. New Delhi: Biotechnology major Biocon and pharma firm Mylan said European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval for their pegfilgrastim biosimilar, Fulphila.  Fulphila is a biosimilar to Amgen’s pegfilgrastim Neulasta, the companies said in a statement. The CHMP positive opinion will now be

The post Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila appeared first on Business | Medical Dialogues.



Related products